Agent-based simulation (ABS) continues to grow in popularity and in its fast-expanding application in various fields. Despite the increased interest, however, a common protocol or standard curriculum ...

In a follow-up analysis to the pivotal TOPAZ-1 study, which established the combination therapy of durvalumab (an ...

NMDPSM, a global nonprofit leader in cell therapy, and its collaborative research program, CIBMTR (Center for International ...